Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Psychopharmacology|May 5, 1998
Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humansL Amass, W K Bickel, J P Crean, et al.European Heart Journal|April 1, 1991
Therapeutic implications of dynamic coronary stenosis in patients with single vessel coronary artery diseaseD Mulcahy, T Crake, P Crean, et al.European Journal of Clinical Pharmacology|January 1, 1984
Sequestration of fentanyl by the cardiopulmonary bypass (CPBP)G Koren, P Crean, J Klein, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplastyA Byrne, N Moran, M Maher, et al.American Heart Journal|November 13, 1998
Impact of intravenous nitroglycerin on pulsed Doppler indexes of left ventricular filling in acute anterior myocardial infarctionT Garadah, N K Ghaisas, N Mehana, et al.The American Journal of Cardiology|April 24, 1999
Early temporal expression of soluble cellular adhesion molecules in patients with unstable angina and subendocardial myocardial infarctionN Mulvihill, J B Foley, N Ghaisas, et al.The American Journal of Cardiology|February 17, 2001
Impact of preexisting statin use on adhesion molecule expression in patients presenting with acute coronary syndromesR T Murphy, J B Foley, N Mulvihill, et al.Journal of the American College of Cardiology|November 18, 2000
Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromesD Cox, R Smith, M Quinn, et al.Gut|April 1, 1989
Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonistG M Fullarton, G McLauchlan, A Macdonald, et al.European Heart Journal|January 1, 1987
Echocardiographic features of right ventricular dilated cardiomyopathy and Uhl's anomalyP A Ribeiro, L M Shapiro, R A Foale, et al.Pageof 8